Equities

Aesthetic Medical International Holdings Group Ltd

Aesthetic Medical International Holdings Group Ltd

Actions
  • Price (EUR)0.214
  • Today's Change0.002 / 0.94%
  • Shares traded0.00
  • 1 Year change-61.44%
  • Beta--
Data delayed at least 15 minutes, as of Nov 21 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CNYIncome statement in CNYView more

Year on year Aesthetic Medical International Holdings Group Ltd had relatively flat revenues (670.09m to 682.59m), though the company grew net income from a loss of 76.25m to a smaller loss of 37.43m. A reduction in the selling, general and administrative costs as a percentage of sales from 56.24% to 54.33% was a component in the net income growth despite flat revenues.
Gross margin45.39%
Net profit margin-7.02%
Operating margin-8.04%
Return on assets-9.06%
Return on equity-131.31%
Return on investment-35.45%
More ▼

Cash flow in CNYView more

In 2023, Aesthetic Medical International Holdings Group Ltd increased its cash reserves by 412.59%, or 50.18m. The company earned 74.29m from its operations for a Cash Flow Margin of 10.88%. In addition the company generated 29.06m cash from financing while 52.25m was spent on investing.
Cash flow per share0.0437
Price/Cash flow per share6.04
Book value per share0.0806
Tangible book value per share-0.026
More ▼

Balance sheet in CNYView more

Aesthetic Medical International Holdings Group Ltd has a Debt to Total Capital ratio of 95.81%, a lower figure than the previous year's 250.59%.
Current ratio0.2379
Quick ratio0.2031
Total debt/total equity8.43
Total debt/total capital0.9581
More ▼

Growth rates in CNY

SmartText is unavailable
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago
--
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.